|
Symbol Name ID |
Ripk2
receptor (TNFRSF)-interacting serine-threonine kinase 2 MGI:1891456 |
Excel File
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Ripk2tm1Cfl/Ripk2tm1Cfl involves: 129S5/SvEvBrd |
abnormal macrophage physiology | J:107130 |
| Ripk2tm1Flv/Ripk2tm1Flv involves: 129S1/Sv |
abnormal cytokine secretion | J:75400 |
| abnormal T-helper 1 physiology | J:75400 | |
| decreased interleukin-6 secretion | J:75400 | |
| decreased T cell proliferation | J:75400 | |
| decreased tumor necrosis factor secretion | J:75400 | |
| Ripk2tm1Flv/Ripk2tm1Flv involves: 129S1/Sv * C57BL/6 |
abnormal macrophage physiology | J:132126 |
| decreased interleukin-6 secretion | J:132126 | |
| decreased tumor necrosis factor secretion | J:132126 | |
| Ripk2tm1Ghc/Ripk2tm1Ghc involves: 129S4/SvJae * C57BL/6 |
decreased IgG2a level | J:75401 |
| decreased interferon-gamma secretion | J:75401 | |
| decreased T cell proliferation | J:75401 | |
| increased susceptibility to infection | J:75401 | |
| Ripk2tm2Cfl/Ripk2tm2Cfl involves: 129S5/SvEvBrd |
normal immune system phenotype | J:107130 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/16/2024 MGI 6.23 |
|
|
|
||
Analysis Tools